Galapagos

About the presentation

Dr. Andre Hoekema will present on Galapagos’ drug discovery engine towards novel mode-of-action medicines based on targets that were identified and validated in human cells.  Some case studies will be presented, including Galapagos’ Alzheimer program.  Andre will also highlight Galapagos’ pharma alliance strategy, which has reduced the investment risk profile of the Company, and allowed the Company to become profitable prior to commercializing a product.

About the speaker
Dr. Hoekema joined Galapagos in March 2005 from Invitrogen Corporation, where he was Managing Director of Corporate Development Europe. He brings 20 years of biotech experience from positions at Molecular Probes Europe (Managing Director), Crucell (Director of Business Development), DSM Life Sciences and MOGEN (Research and Project Management) and Genentech, Inc (R&D). Dr. Hoekema has a PhD degree from Leiden University and is the inventor of over 20 series of patent applications, resulting in 15 patents issued in the US.